Silence Therapeutics PLC

-

Stock Issuer and Owners

Home | Sign Up | Log In
List of Funds
Boston Firms
Boston Hedge Funds
Cornell Alumni Firms
CalPERS Portfolio
NYSCRF Portfolio
Latest Filings
User Guide
Regulatory AUM vs AUM
LP Portfolios
Related Firms
Build a Portfolio
Comprehensive Search
Silence Therapeutics PLC
TickerSLN
CIK #0001479615
CUSIP82686Q101
SectorLife Sciences - Pharmaceutical Preparations
Address72 Hammersmith Road, London, W14 8TH
Source [EDGAR]
CIK Filing 2011 - 2024
[0001479615] 6-K
[0001479615] D
[0001479615] SC 13D
[0001479615] SC 13G
Form 13D/13G Filer Form 13D/13G Subject Filed % Owned
Deep Track Capital LP Silence Therapeutics PLC [2022-08-22] 5.44
TCG Crossover Management LLC Silence Therapeutics PLC [2022-08-19] 5.9
Griffiths Richard Ian Silence Therapeutics PLC [2022-06-15] 27.0
Quested Robert Silence Therapeutics PLC [2022-02-14] 7.81
Griffiths Richard Ian Silence Therapeutics PLC [2022-02-14] 23.05
Mallinckrodt PLC Silence Therapeutics PLC [2022-02-07] 5.64
Goldman Sachs Group Inc Silence Therapeutics PLC [2022-01-27] 5.4
Keith Robert Napier Silence Therapeutics PLC [2021-02-17] 13.7
Griffiths Richard Ian Silence Therapeutics PLC [2021-02-17] 23.3
Quested Robert Silence Therapeutics PLC [2021-02-17] 8.5
Lombard Odier Asset Management USA Corp Silence Therapeutics PLC [2021-02-16] 12.2
Silence Therapeutics PLC Arrowhead Pharmaceuticals Inc [2017-12-01] 6.4
Form 13F Holdings
Firm Period DFND Voting Shares
Lombard Odier Asset Management USA Corp [2023-03-31] OTR 3,959,101.0 3,959,101.0
Lombard Odier Asset Management (Europe) Ltd [2023-03-31] OTR 3,293,405.0 3,293,405.0
TCG Crossover Management LLC [2023-03-31] SOLE 2,104,875.0 2,104,875.0
Deep Track Capital LP [2023-03-31] SOLE 1,951,580.0 1,951,580.0
BVF Inc/IL [2023-03-31] DFND 0.0 1,508,416.0
Aquilo Capital Management LLC [2023-03-31] SOLE 1,312,233.0 1,312,233.0
Frazier Life Sciences Management LP [2023-03-31] SOLE 881,173.0 881,173.0
Goldman Sachs Group Inc [2023-03-31] DFND 660,000.0 660,000.0
AXA Sa [2023-03-31] DFND 516,416.0 516,416.0
Artal Group S.A. [2023-03-31] DFND 505,074.0 505,074.0
Point72 Asset Management LP [2023-03-31] DFND 0.0 349,462.0
Cantor Fitzgerald L P [2023-03-31] DFND 0.0 289,158.0
HSBC Holdings PLC [2023-03-31] DFND 177,834.0 177,834.0
Parkman Healthcare Partners LLC [2023-03-31] SOLE 158,774.0 158,774.0
M28 Capital Management LP [2023-03-31] SOLE 145,900.0 145,900.0
Woodline Partners LP [2023-03-31] SOLE 143,684.0 143,684.0
UBS OConnor LLC [2023-03-31] DFND 95,383.0 95,383.0
Morgan Stanley [2023-03-31] DFND 72,677.0 72,677.0
UBS Group AG [2023-03-31] SOLE 69,006.0 69,006.0
Citigroup Inc [2023-03-31] DFND 58,333.0 58,333.0
Blair William & Co/IL [2023-03-31] SOLE 41,263.0 41,263.0
Schonfeld Strategic Advisors LLC [2023-03-31] SOLE 41,100.0 41,100.0
WS Management LLLP [2023-03-31] SOLE 25,000.0 25,000.0
Millennium Management LLC [2023-03-31] SOLE 19,684.0 19,684.0
Geode Capital Management LLC [2023-03-31] DFND 14,687.0 14,687.0
Cubist Systematic Strategies, LLC [2023-03-31] DFND 0.0 2,600.0
Deutsche Bank AG [2023-03-31] DFND 620.0 620.0
Bank of America Corp /DE/ [2023-03-31] DFND 0.0 550.0
Steward Partners Investment Advisory LLC [2023-03-31] SOLE 0.0 100.0
Concourse Financial Group Securities Inc [2023-03-31] SOLE 0.0 0.0
Prev | Page 88 | Next
Terms | Privacy | Guide
tony@aum13f.com